Vivos Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 74.6% | -120.7% | -120.2% |
| FY2022 | 62.5% | -156.2% | -148.8% |
| FY2023 | 59.9% | -125.3% | -98.4% |
| FY2024 | 60.0% | -74.3% | -74.1% |
| FY2025 | 60.4% | -114.1% | -121.4% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 74.6% | -120.7% | -120.2% |
| FY2022 | 62.5% | -156.2% | -148.8% |
| FY2023 | 59.9% | -125.3% | -98.4% |
| FY2024 | 60.0% | -74.3% | -74.1% |
| FY2025 | 60.4% | -114.1% | -121.4% |